Sun Pharmaceuticals to consider raising $1.55 billion via debentures

Sun Pharmaceuticals, a major Indian pharmaceutical company, is considering raising $1.55 billion through debenture issuance. The move reflects the company's efforts to strengthen its capital base and fund future operations or expansion plans.

Debentures are unsecured debt instruments, a common financing method for large corporations to access capital markets.